What are the recommended dose and contraindications for the combination of orphenadrine and paracetamol?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: July 6, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Orphenadrine Plus Paracetamol: Dosing and Contraindications

The standard adult dose for orphenadrine plus paracetamol combination is one tablet containing 35-50 mg orphenadrine and 325-450 mg paracetamol, taken 3 times daily, with absolute contraindications including tachycardia, cardiac arrhythmias, coronary insufficiency, cardiac decompensation, and glaucoma.

Recommended Dosing

Oral Combination Therapy

  • Standard dose: 1 tablet containing orphenadrine 35-50 mg plus paracetamol 325-450 mg, administered 3 times daily 1, 2
  • Maximum paracetamol: Do not exceed 4 g/day total paracetamol from all sources 3
  • FDA guidance: Combination products should limit paracetamol to ≤325 mg per dosage unit to reduce hepatotoxicity risk 4

Parenteral Orphenadrine (when combination not available)

  • IV/IM dose: 60 mg (one 2 mL vial) every 12 hours 5
  • Transition: May switch to oral orphenadrine 100 mg tablets twice daily for maintenance 5

Critical Dosing Considerations

The combination demonstrates superior analgesic efficacy compared to paracetamol alone, with statistically significant pain relief beginning on day 2-3 of treatment 1, 2. When using fixed-dose combinations, you must account for total paracetamol intake from all sources - this is a common pitfall that leads to inadvertent overdosing 4, 6, 4.

Absolute Contraindications

Cardiac conditions 5:

  • Tachycardia
  • Cardiac arrhythmias
  • Coronary insufficiency
  • Cardiac decompensation

Other absolute contraindications:

  • Glaucoma (orphenadrine has anticholinergic effects) 5
  • Known hypersensitivity to orphenadrine or paracetamol 4

Relative Contraindications and Cautions

Hepatic Considerations

  • Liver disease/cirrhosis: Use paracetamol with extreme caution; reduce dose to 2-3 g/day maximum 3, 7
  • Chronic alcohol use: Limit paracetamol to 2-3 g/day despite older concerns about 4 g dosing 7
  • Active liver failure: Paracetamol should be avoided or used at significantly reduced doses 3

Renal Impairment

  • Exercise caution with paracetamol in chronic kidney disease 6
  • Monitor renal function if prolonged use is necessary

Drug Interactions

  • Propoxyphene: Concomitant use may cause confusion, anxiety, and tremors; reduce dosage or discontinue one agent 5
  • Warfarin/anticoagulants: Monitor closely due to paracetamol effects on INR
  • Other anticholinergic medications: Additive anticholinergic effects possible

Special Populations

  • Pregnancy: Category C - use only if clearly needed 5
  • Pediatric: Safety not established; not recommended in children 5
  • Elderly: Use with caution due to anticholinergic effects and increased fall risk

Monitoring Requirements

For prolonged therapy (though long-term safety is not established) 5:

  • Periodic blood counts
  • Liver function tests
  • Renal function tests
  • Urinalysis

Clinical Efficacy Context

The combination of orphenadrine and paracetamol is specifically effective for musculoskeletal pain with muscle spasm, particularly myalgia and cervical/thoracic muscle tension 1, 2, 8. The orphenadrine component provides both muscle relaxant and mild analgesic properties, while paracetamol contributes additional analgesia 8. This combination shows superior efficacy over paracetamol alone in controlled trials, with pain relief evident within 30 minutes and sustained through 6 hours 9.

Key Clinical Pitfalls to Avoid

  1. Paracetamol stacking: Always calculate total daily paracetamol from combination products, over-the-counter medications, and other prescriptions
  2. Cardiac screening: Screen for cardiac contraindications before prescribing orphenadrine
  3. Anticholinergic burden: Avoid in patients already taking multiple anticholinergic medications
  4. Duration misconception: This is for acute/subacute pain management, not chronic long-term therapy
  5. Alcohol history: Actively inquire about alcohol use to adjust paracetamol dosing appropriately

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.